962 related articles for article (PubMed ID: 26485275)
1. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
[TBL] [Abstract][Full Text] [Related]
2. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY
Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128
[TBL] [Abstract][Full Text] [Related]
3. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
[TBL] [Abstract][Full Text] [Related]
4. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.
Mantel HT; Wiggers JK; Verheij J; Doff JJ; Sieders E; van Gulik TM; Gouw AS; Porte RJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1107-15. PubMed ID: 26178761
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of suppresser of cytokine signaling 3 inhibits the IL-6-induced epithelial-to-mesenchymal transition and cholangiocarcinoma cell metastasis.
Zhou QX; Jiang XM; Wang ZD; Li CL; Cui YF
Med Oncol; 2015 Apr; 32(4):105. PubMed ID: 25744243
[TBL] [Abstract][Full Text] [Related]
6. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.
Thuwajit P; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-In S
J Gastroenterol Hepatol; 2008 May; 23(5):771-8. PubMed ID: 18410610
[TBL] [Abstract][Full Text] [Related]
9. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.
Chua-On D; Proungvitaya T; Techasen A; Limpaiboon T; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sungkhamanon S; Proungvitaya S
Tumour Biol; 2016 Oct; 37(10):13659-13667. PubMed ID: 27473083
[TBL] [Abstract][Full Text] [Related]
10. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
13. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
14. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
Su MC; Hsu C; Kao HL; Jeng YM
Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
[TBL] [Abstract][Full Text] [Related]
15. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
Xiong GP; Zhang JX; Gu SP; Wu YB; Liu JF
Neoplasma; 2012; 59(4):409-15. PubMed ID: 22489696
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of microRNA-203 in cholangiocarcinoma.
Li J; Gao B; Huang Z; Duan T; Li D; Zhang S; Zhao Y; Liu L; Wang Q; Chen Z; Cheng K
Int J Clin Exp Pathol; 2015; 8(8):9512-6. PubMed ID: 26464713
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinical significance of hepatoma-derived growth factor as a prognostic factor in human hilar cholangiocarcinoma.
Liu YF; Zhao R; Guo S; Wang XQ; Lian PL; Chen YG; Xu KS
Ann Surg Oncol; 2011 Mar; 18(3):872-9. PubMed ID: 20848225
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]